tiprankstipranks
Trending News
More News >
BB Biotech AG (CH:BION)
:BION
Switzerland Market

BB Biotech (BION) Ratios

Compare
7 Followers

BB Biotech Ratios

CH:BION's free cash flow for Q2 2025 was CHF1.00. For the 2025 fiscal year, CH:BION's free cash flow was decreased by CHF and operating cash flow was CHF0.07. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.00 19.88 158.32 <0.01 <0.01
Quick Ratio
0.00 19.88 158.32 <0.01 <0.01
Cash Ratio
0.00 <0.01 0.03 <0.01 <0.01
Solvency Ratio
-70.60 0.63 -1.19 -1.83 -2.11
Operating Cash Flow Ratio
0.00 2.51 13.10 -0.97 -0.26
Short-Term Operating Cash Flow Coverage
0.00 2.59 0.72 -0.99 -0.27
Net Current Asset Value
CHF 97.95MCHF 2.29BCHF 2.32BCHF -365.31MCHF -352.17M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.05 0.12 0.12 0.10
Debt-to-Equity Ratio
0.00 0.05 0.13 0.14 0.11
Debt-to-Capital Ratio
0.00 0.05 0.12 0.12 0.10
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.12 0.00
Financial Leverage Ratio
1.00 1.05 1.14 1.14 1.11
Debt Service Coverage Ratio
-0.02 0.65 -0.65 -0.98 -1.13
Interest Coverage Ratio
-25.67 16.95 -5.16 -22.38 -53.34
Debt to Market Cap
0.00 0.06 0.13 0.24 0.08
Interest Debt Per Share
0.04 2.23 5.67 6.63 6.43
Net Debt to EBITDA
0.00 1.46 -1.51 -1.01 -0.87
Profitability Margins
Gross Profit Margin
100.00%100.00%100.00%100.00%100.00%
EBIT Margin
-22.78%71.96%-98865.71%-1075325.00%14.94%
EBITDA Margin
0.00%71.88%-575017.14%-8932150.00%101.66%
Operating Profit Margin
29.55%75.61%-85508.57%-965525.00%13.27%
Pretax Profit Margin
249.02%68.04%-590080.00%-8943775.00%102.15%
Net Profit Margin
249.05%67.99%-590305.71%-8945300.00%102.17%
Continuous Operations Profit Margin
249.05%67.99%-590305.71%-8945300.00%102.17%
Net Income Per EBT
100.01%99.93%100.04%100.02%100.02%
EBT Per EBIT
842.57%89.99%690.08%926.31%769.54%
Return on Assets (ROA)
-15.75%3.15%-7.83%-11.72%-11.11%
Return on Equity (ROE)
-19.82%3.32%-8.89%-13.32%-12.33%
Return on Capital Employed (ROCE)
-1.87%3.69%-1.14%-1.44%-1.60%
Return on Invested Capital (ROIC)
-1.87%3.51%-0.54%-1.27%-1.45%
Return on Tangible Assets
-15.75%3.15%-7.83%-11.72%-11.11%
Earnings Yield
-17.15%3.90%-8.82%-11.78%-9.48%
Efficiency Ratios
Receivables Turnover
-31.95 0.00 0.02 0.00 0.00
Payables Turnover
0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
-0.06 0.05 <0.01 <0.01 -0.11
Working Capital Turnover Ratio
-0.18 0.05 <0.01 >-0.01 -0.22
Cash Conversion Cycle
-11.43 0.00 19.07K 0.00 0.00
Days of Sales Outstanding
-11.43 0.00 19.07K 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 0.00 0.00 0.00 0.00
Operating Cycle
-11.43 0.00 19.07K 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
7.95 5.54 3.98 -6.50 -1.71
Free Cash Flow Per Share
7.95 5.54 3.98 -6.50 -1.71
CapEx Per Share
0.00 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
4.42 2.78 1.40 -1.69 -0.48
Capital Expenditure Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
0.00 2.59 0.72 -0.99 -0.27
Operating Cash Flow to Sales Ratio
-2.47 2.73 6.24K -89.45K 0.24
Free Cash Flow Yield
16.92%15.64%9.32%-11.78%-2.22%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-5.83 25.65 -11.34 -8.49 -10.55
Price-to-Sales (P/S) Ratio
-14.62 17.44 66.94K 759.15K -10.78
Price-to-Book (P/B) Ratio
0.92 0.85 1.01 1.13 1.30
Price-to-Free Cash Flow (P/FCF) Ratio
5.91 6.39 10.73 -8.49 -45.06
Price-to-Operating Cash Flow Ratio
5.87 6.39 10.73 -8.49 -45.06
Price-to-Earnings Growth (PEG) Ratio
1.97 -0.19 0.27 0.77 0.07
Price-to-Fair Value
0.92 0.85 1.01 1.13 1.30
Enterprise Value Multiple
0.00 25.72 -13.15 -9.51 -11.48
Enterprise Value
2.48B 2.06B 2.65B 3.40B 4.62B
EV to EBITDA
0.00 25.72 -13.15 -9.51 -11.48
EV to Sales
-14.06 18.49 75.64K 849.41K -11.67
EV to Free Cash Flow
5.69 6.78 12.13 -9.50 -48.78
EV to Operating Cash Flow
5.69 6.78 12.13 -9.50 -48.78
Tangible Book Value Per Share
50.73 41.57 42.39 48.83 59.41
Shareholders’ Equity Per Share
50.73 41.57 42.39 48.83 59.31
Tax and Other Ratios
Effective Tax Rate
>-0.01 <0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
-3.22 2.03 <0.01 <0.01 -7.16
Net Income Per Share
-8.01 1.38 -3.77 -6.50 -7.31
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
-10.93 0.95 5.97 8.32 6.84
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
-0.15 0.24 120.77 1.03K -0.02
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 0.00 -1.06 1.00 0.23
Currency in CHF